NEW YORK--(BUSINESS WIRE)--CurePSP, the foundation for prime of life neurodegeneration, has appointed Gregg Felice, LCSW-R, as Director – Patient & Carepartner Advocacy.
Mr. Felice will work to strengthen, train, and expand CurePSP’s network of 66 in-person support groups and 100 volunteers offering online and telephone support, work with CurePSP’s Centers of Care, and develop and cultivate partnerships with industry, academia, foundations, and other nonprofits in the neuroscience space. Joanna Teters, Community Outreach & Resource Manager, will report to Mr. Felice.
“CurePSP has built a culture of caring around its programs to support patients, families, and other caregivers in their daily struggles with progressive supranuclear palsy (PSP) and related neurodegenerative diseases,” said David Kemp, president of the foundation. “Gregg has extensive professional training and experience and had personal involvement as caregiver to his father, who unfortunately passed away from PSP. We expect Gregg will help to expand our offering to patients and families who are coping with the stress and impact of managing a difficult diagnosis by providing additional programs, support, and counseling.”
Mr. Felice has worked in healthcare for 25 years, 13 of those as a social worker. His experience includes all aspects of accessing patient assistance programs, funding and resources, education of physicians’ office staff, and overcoming barriers to obtaining insurance coverage. Mr. Felice was most recently regional account manager for specialty sales and services for Walgreens Specialty Pharmacy servicing the Westchester, Bronx, Hudson Valley, and Manhattan North territory. Earlier, he was hospital account manager for Bioscrip and was a clinical oncology social worker at Westchester Medical Center. He received his master’s degree in social work from Adelphi University and his bachelor’s degree in psychology from SUNY New Paltz.
CurePSP is the foundation for prime of life neurodegeneration, a spectrum of fatal brain disorders that often strike during a person's most productive and rewarding years. Currently, there is no effective treatment or cure for these diseases, which afflict an estimated 150,000 people in the U.S. Since its founding in 1990, CurePSP has funded more than 190 research studies and is the leading source of support and advocacy for patients, their families, and other caregivers. CurePSP’s 22 Centers of Care are chosen for their superior facilities and personnel who are qualified to serve the needs of PSP and other movement-disorders patients. CurePSP also provides education and awareness to doctors and allied healthcare professionals and the general public. CurePSP is based in New York City. Please visit www.curepsp.org for more information.